Marseille Immunopole ©2019 Legal notice & Privacy statement
To date, The Pioneer Project benefits from the commitment of 11 partner centers.
An update of The Pioneer Project RHU: 104 patients in the biomarker component, 2 patients in the umbrella clinical trial.
Immuno-oncology and lung cancer highlights: episode 2 (Q4 2019)
Update of the Pioneer Project RHU: while 91 patients have already been included in the biomarker component of the project, a first patient is entered in the Pioneer’s clinical trial
Overcome resistance to anti-PD1(L1) immunotherapy: first lung cancer patient enrolled in the Pioneer Project’s clinical trial
An update of The Pioneer Project RHU: A total inclusion of 86 patients in the biomarker component of the project
The RHU progresses as expected with a total inclusion of 79 patients in the biomarker component of the project
The Pioneer Project RHU appoints world-renowned experts to its Scientific Advisory Board
With the commitment of 11 partner centers and 46 patients included in the biomarker component of the project, the RHU has entered a new phase
Immuno-oncology and lung cancer: highlights 2018
Launch of PIONEER, a major international research project in lung cancer